Study finds lifelong doubling in death risk for men who are obese at age 20 years

July 13, 2010

Stockholm, Sweden: Men who enter adult life obese face a life-long doubling of the risk of dying prematurely, new research has found.

In a study presented today (Tuesday) at the International Congress on Obesity in Stockholm, researchers tracked more than 5,000 military conscripts starting at the age of 20 until up to the age of 80. They found that at any given age, an obese man was twice as likely to die as a man who was not obese and that obesity at age 20 years had a constant effect on death up to 60 years later. They also found that the chance of dying early increased by 10% for each BMI point above the threshold for a healthy weight and that this persisted throughout life, with the obese dying about eight years earlier than the non-obese.

"As the obesity epidemic is still progressing rapidly, especially among children and adolescents, it is important to find out if obesity in early adulthood has lifelong mortality effects," said the study's leader, Esther Zimmermann, a researcher at the Institute of Preventive Medicine, Copenhagen University Hospital and the Institute of Biomedical Sciences at University of Copenhagen in Denmark. "Previous studies have investigated obesity and mortality in middle-aged populations, which only tells us about the detrimental effects of obesity in middle age. Our study sheds light on how obesity at age 20 years affects obesity throughout adult life. It is the first study with such a long follow-up time and thus the first study to investigate the lifelong effect."

In the study, the researchers compared mortality in a sample of 1,930 obese male military conscripts with that in a random sample of 3,601 non-obese male conscripts. Body mass index (BMI) was measured at the average ages of 20, 35 and 46 years, and the researchers investigated that in relation to death in the next follow-up period. A total of 1,191 men had died during the follow-up period of up to 60 years. The results were adjusted to eliminate any influence on the findings from year of birth, education and smoking.

"At age 70 years, 70% of the men in the comparison group and 50% of those in the obese group were still alive and we estimated that from middle age, the obese were likely to die eight years earlier than those in the comparison group," Zimmermann said. The researchers also investigated the effect of the broad BMI range on mortality from the age of 20 and found the lowest death risk in the men who had a BMI of 25. Underweight men had a slightly elevated risk, and the risk of early death crept up steadily by 10% for each BMI unit above 25 for those men who were overweight or obese.

Zimmermann said it is unclear whether it is being obese at age 20 that conferred the men's increased death risk or whether the lifelong effect is due to obesity often being a lifelong condition for them. She said more research is warranted to find the answer to that question.

"More than 70% of the obese young men were still obese at the follow-up examinations, whereas only 4% of the men in comparison group developed obesity during follow-up. Obesity seems to be a persistent condition and it appears that if it has not occurred in men by the age of 20, the chance of it developing later are quite low. The persistence of obesity may partly explain why obesity at 20 years of age has lifelong mortality effects, but it needs to be proven whether that is the full explanation or whether, by itself, being obese at an early age increases the risk of early death," she said.

Zimmermann said her group plans to study the patterns of ill health that caused the early death in the obese group, in order to determine whether the same diseases are causing death at different ages. Such information may shed some light on the mechanisms through which obesity works at different ages, she said.
-end-
Her study was funded by grants from the Cluster for Endocrinology and Metabolism, University of Copenhagen, Denmark.

Catalogue no: T4:OS4.4 oral presentation, Victoria Hall, 14.00 hrs CEST Tuesday 13 July

International Association for the Study of Obesity

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.